Keto-Mojo

🌎 Take control of your metabolic health
🩸 Glucose & ketone testing made easy
📈 FDA-cleared GK+ Meter

[Keto-Mojo @KetoMojo]

When weight loss is matched, does diet composition still matter?

In this randomized clinical trial, 55 adults with obesity, prediabetes, and fatty liver were assigned to ketogenic, Mediterranean, or very-low-fat plant-forward diets. Metabolic outcomes were compared after ~10% weight loss.

🔹 Liver fat fell 67% with the ketogenic diet vs 45% with both other diets.

🔹 Hepatic insulin sensitivity improved 2–3 times more with the ketogenic diet.

🔹 24-hour insulin levels fell 74%, compared with 44% and 27% on the Mediterranean and very-low-fat diets.

🔹 Prediabetes remission occurred in 50% of the ketogenic group vs 29% and 7% in the other groups.

The findings suggest that macronutrient composition may influence the metabolic benefits of weight loss, particularly liver and glucose metabolism.

—

Petersen MC, Smith GI, Farabi SS, Palacios HH, Shankaran M, Hellerstein MK, Patterson BW, Klein S. Effect of diet macronutrient content on the cardiometabolic response to weight loss: A randomized clinical trial. _Cell Metab._2026;38:1–12

📌 Link to study: https://t.co/dCQNJaAfK1

📌 Find more research summaries on our website: https://t.co/iJavUH3WTx

#KetogenicDiet #MetabolicHealth #Prediabetes #FattyLiver #Research

[Keto-Mojo @KetoMojo]

@Metabolic_Mind Dyane is an inspiration and a great example for those wanting to follow a keto-vegan diet! Such a lovely person to highlight in this interview.

[Keto-Mojo @KetoMojo]

That’s a wrap on the Health Optimisation Summit!

Our biggest takeaway? The more we understand our individual biology, the more metabolically intelligent we become - empowering us to make more informed decisions about our health.

Thank you to everyone who stopped by, tested with us, asked questions, and shared your stories. We loved connecting with you!

And a huge thank you to @TimBiohacker, the entire @HOsummit team, all the exhibitors, and the incredible volunteers who made such a dynamic weekend possible.

See you next year, London! 🇬🇧

#HealthOptimisationSummit #Biohacking #MetabolicHealth #Longevity #DataDrivenHealth #MetabolicIntelligence

[Keto-Mojo @KetoMojo]

Metabolic health doesn’t stop at your metabolism.

That idea took center stage at the @HOsummit where Keto-Mojo founder Dorian Greenow presented “How to Change Nearly Every Cell in Your Body.”

He packed the house, exploring how metabolic health impacts the entire body and how tracking your biomarkers can make it measurable and personal.

What’s one thing you learned at this year’s Summit that changed how you think about your health?

#HealthOptimisationSummit #Biohacking #MetabolicHealth #Longevity #DataDrivenHealth #MetabolicIntelligence

[Keto-Mojo @KetoMojo]

In case there was any question — yes, we have the best co-founder.

Happy Birthday, Gemma!

#KetoMojo #Ketogether #WhatsYourMojo

[Keto-Mojo @KetoMojo]

Nicoya Stage** 3pm

See you there!

[Keto-Mojo @KetoMojo]

Ello London! We’re live at @HOSummit 🇬🇧

Pop by Booth S15 to talk metabolic health — get your glucose and ketones tested at the same time.

Tomorrow, our founder, Dorian Greenow, takes the main stage for “How to Change Nearly Every Cell in Your Body.”

📅 Sept 12 | 3 PM

#HealthOptimisationSummit #Biohacking #MetabolicHealth #Longevity #DataDrivenHealth #MetabolicIntelligence

[Keto-Mojo @KetoMojo]

Can a nutrition-focused, remote care program reduce liver disease risk in high-risk adults?

In a large U.S. matched cohort study (n=10,062), Virta Individualized Nutrition Therapy (VINT) – a telemedicine program designed to achieve nutritional ketosis and promote metabolic health – was compared with usual care.

Over an average of 2 years, the VINT participants had a consistently lower incidence of liver-related outcomes:

🔹 ~39% lower relative risk of any liver-related diagnosis (HR 0.61)
🔹 ~62% lower relative risk of progressive liver disease (MASH and beyond; HR 0.38)
🔹 ~67% lower relative risk of advanced liver disease (HR 0.33)
🔹 ~75% lower relative risk of liver-related complications (HR 0.25) 🔹Greater weight loss was also associated with lower risk: ≥15% weight loss, ~34% lower relative risk (HR 0.66)

Despite similar medication use and healthcare utilization, fewer liver-related events were observed in the VINT participants.

These findings support a lifestyle-first, metabolically targeted approach as a scalable strategy to reduce liver disease risk.

—

Athinarayanan SJ, Wolfberg AJ, Shanmugam PV, Hameed BA, Bonacini M. Reduced risk of liver-related events among patients receiving individualized nutrition-focused remote care in the United States. Hepatology. 2026; 10.1097

📌 Link to study: https://t.co/dOBIN803JH

📌 Find more research summaries on our website: https://t.co/iJavUH3WTx

#MetabolicHealth #KetogenicDiet #Ketosis #MASLD #NutritionScience

[Keto-Mojo @KetoMojo]

Following a ketogenic lifestyle doesn't mean missing out on social events. With a little planning, you can enjoy meals with family and friends while staying true to your health goals.

This article shares eight practical strategies for navigating restaurants, parties, and other social gatherings with confidence.

🔗 https://t.co/UFPJA0cFIY

#KetoDiet #LowCarbLiving #MetabolicHealth #NutritionTips

[Keto-Mojo @KetoMojo]

This week our founder, Dorian Greenow, takes the stage at @HOsummit in London to explore “How to Change Nearly Every Cell in Your Body for Optimal Health and Longevity.”

He'll be joined by leading voices in metabolic health: neuroscientist @TaraSwart, women’s health specialist @drlouisenewson, health and performance expert @bengreenfield, nutrition expert @jjvirgin, psychiatrist Dr. Judith Joseph, summit founder @TimBiohacker, and more.

📍 Business Design Centre, London
📅 Health Optimisation Summit: September 11–13

🩵 The Keto-Mojo team will also be there; come say hi! Booth S15.

Get your tickets now: https://t.co/0TOMyj2Ia9

Use code KETOMOJO for 10% off tickets. **We will earn a commission on every ticket sold through the referral link.**

If you're attending, let us know in the comments 👇

#MetabolicHealth #KetogenicDiet #KetoMojo #Ketogether #MojoMeetUp

[Keto-Mojo @KetoMojo]

This case report describes the experience of a 60-year-old woman with recurrent pancreatic ductal adenocarcinoma (PDAC) who stabilized her disease for 9 months using a ketogenic diet after declining further chemotherapy due to side effects. PDAC has a poor prognosis, and survival after recurrence is typically less than 1 year.

After initial chemotherapy and surgery, she completed additional chemotherapy and radiotherapy for lung metastases. When the cancer progressed again, she began a strict ketogenic diet (<50 g carbohydrates, high fat with medium-chain triglycerides), with meals supervised by a dietitian for 3 months. Urine ketones were monitored daily.

Key outcomes:

🔹Disease remained stable for 9 months on the ketogenic diet alone; lung metastases showed minimal size change.

🔹 Tumor marker (CA19-9) levels remained steady.

🔹 The diet was well tolerated, with no reports of hunger, hair loss, or other side effects.

🔹 Disease progressed at 12 months, at which point chemotherapy was reintroduced.

🔹 The patient lived 24 months after starting the diet.

🔹 The tumor showed high GLUT-1 expression, suggesting sensitivity to glucose restriction.

This case highlights the potential role of ketogenic therapy in select patients with pancreatic cancer, although more research is needed.

—

Einama T, Yonamine N, Hatakeyama M, Ogata S, Kobayashi K, Shinada H, Tsunenari T, Takihata Y, Takao M, Ueno H, Kishi Y. Postoperative recurrence of pancreatic cancer controlled for 9 months solely by severe carbohydrate restriction: ketogenic diet. Clin J Gastroenterol. 2025.

📌 Link to study: https://t.co/20Gf6zbqHM

📌 Find more research summaries on our website: https://t.co/iJavUH3WTx

#KetogenicDiet #Oncology #PancreaticCancer #Research

[Keto-Mojo @KetoMojo]

🧠 Can certain dietary approaches slow biological aging in multiple sclerosis (MS)? A new secondary analysis suggests it might.

Researchers conducted a secondary analysis of two trials to evaluate three dietary approaches in people with MS, using metabolomic age (mAge), a biomarker based on blood metabolites, to measure biological aging.

🔹A 6-month ketogenic diet (low-carb, high-fat) reversed biological aging by about one year per month.

🔹 An 8-week intermittent calorie restriction plan (two very-low-calorie days per week) reduced mAge by an average of 6.6 years.

🔹In contrast, daily calorie restriction (with similar weight loss) had no effect on mAge.

These findings suggest that the benefits go beyond calorie deficit alone, potentially involving ketone production, mitochondrial function, inflammation, and gut microbiome changes.

This positions mAge as a useful biomarker in MS research and supports dietary strategies as possible adjuncts to treatment. However, larger and longer trials are needed to determine clinical relevance.

—

Siavoshi F, Smith MD, Cassard S, Moreau GB, Brenton JN, Mowry EM, Fitzgerald KC, Bhargava P. Fasting mimicking diets reverse accelerated biological aging in multiple sclerosis. Ann Neurol. 2025 Sep 19.

📌 Link to study: https://t.co/EBclpj31rn

📌 Find more research summaries on our website: https://t.co/iJavUH3WTx

#MultipleSclerosis #KetogenicDiet #IntermittentFasting #Ketosis #Research

[Keto-Mojo @KetoMojo]

New research suggests that a ketogenic diet may enhance the effectiveness of metabolic therapies against pediatric high-grade glioma.

In this preclinical study, juvenile mouse models of high-grade glioma received a ketogenic diet (KD) alone or combined with the metabolic drugs mebendazole (MBZ) or devimistat.

Key findings:

🔹 KD lowered blood glucose, increased β-hydroxybutyrate (BHB), and reduced tumor invasion

🔹 MBZ + KD reduced tumor growth and invasion while prolonging survival compared with KD alone

🔹 Devimistat demonstrated in vivo benefit only when combined with KD

🔹 Both MBZ + KD and devimistat + KD significantly improved survival in a second glioma model

🔹 KD helped maintain body weight, with no evidence of obvious MBZ-related liver toxicity

These findings are encouraging but preliminary. Because this was a preclinical study in cell and animal models, clinical trials are needed to determine whether these metabolic therapies can improve outcomes for children with high-grade glioma.

—

Mukherjee P, Maurer J, Stopka SA, Greenwood B, Aristizabal-Henao JJ, Karmacharya S, Chimento A, Ta N, Lee DC, Duraj T, Bronson RT, Kiebish MA, Seyfried TN. Ketogenic diet as a metabolic vehicle enhancing the therapeutic efficacy of mebendazole and devimistat in juvenile syngeneic high-grade glioma_._ Cell Rep Med. 2026;7:102845. doi:10.1016/j.xcrm.2026.102845. @tnseyfried @drtomasduraj

📌 Link to study: https://t.co/ehGe2fodXT

📌 Find more research summaries on our website: https://t.co/iJavUH3WTx

#KetogenicDiet #Ketosis #BrainCancer #PediatricCancer

[Keto-Mojo @KetoMojo]

In just a few weeks, our founder, Dorian Greenow, takes the stage at the @HOsummit in London to explore “How to Change Nearly Every Cell in Your Body for Optimal Health and Longevity.”

He'll be joined by leading voices in metabolic health: neuroscientist @TaraSwart, women’s health specialist @drlouisenewson, health and performance expert @bengreenfield, nutrition expert @jjvirgin, psychiatrist Dr. Judith Joseph, summit founder @TimBiohacker, and more.

📍 Business Design Centre, London
📅 Health Optimisation Summit: September 11–13

🩵 The Keto-Mojo team will also be there; come say hi at our booth!

Get your tickets now: https://t.co/0TOMyj2Ia9

Use code KETOMOJO for 10% off tickets. **We will earn a commission on every ticket sold through the referral link.**

If you’re attending, let us know in the comments 👇

#MetabolicHealth #KetogenicDiet #KetoMojo #Ketogether #MojoMeetUp

[Keto-Mojo @KetoMojo]

Many women reach a point where they feel like they've somehow lost themselves – physically, mentally, or emotionally – but struggle to explain why.

In this thoughtful guest post, Ally Houston explores why these experiences are more common than many realize and why recognizing them may be the first step toward feeling like yourself again.

🔗 https://t.co/o8MQsaTQn4

#WomensHealth #MetabolicHealth #HealthyAging #BrainHealth #Wellbeing

[Keto-Mojo @KetoMojo]

Symposium for Metabolic Health 2026 is a wrap! 🎉 @lowcarbusa® @TheSMHP

What an incredible community of attendees, speakers, researchers, practitioners, and metabolic health leaders who came together to share ideas, challenge conventional thinking, and move the conversation forward.

Our biggest takeaways:

🌴 Metabolic health isn't just one-size-fits-all. It's about using measurable data and personalized insights to help individuals discover what works for them.

🌴 The future of metabolic health is connected. Nutrition, technology, real-time biomarkers, and personalized care are coming together to make prevention more actionable and accessible.

We already miss the conversations, keto treats, and insights shared by the speakers and attendees throughout the symposium.

A huge shout-out to @DougieReynolds and @LCPamDevine for bringing together such a wonderful event and community.

Stay salty, San Diego!

@carbaddictiondr, Michael Hoffmann, @doctorkiltz, @lilyej, @siobhan_huggins, @drtonyhampton, @AdrianSotoMota, @DrElenaGross, @realDaveFeldman, Guido K.W. Frank, Dr. Ana Rosa, Henry Walker, Pharmacist, Metabolic Health Practitioner, @BrianLenzkes, @DrSeanOMara

#SMHSD26 #MetabolicHealth #RootCauseMedicine #MyHealthMetrics #KetoneTesting #KetoDiet #LowCarb

[Keto-Mojo @KetoMojo]

Could the glucose ketone index (GKI) become a simple way to monitor metabolic health across cancer and other chronic diseases?

This review explores growing evidence that mitochondrial dysfunction contributes to conditions including cancer, type 2 diabetes, cardiovascular disease, obesity, neurodegenerative disorders, and some psychiatric illnesses. The authors propose that the GKI – calculated by dividing blood glucose by blood β-hydroxybutyrate (BHB) – may provide a practical way to monitor ketogenic metabolic therapy, which may help restore mitochondrial function.

🔹 Mitochondrial dysfunction may be a shared driver of many chronic diseases.

🔹 Ketogenic metabolic therapy may improve mitochondrial energy production while reducing oxidative stress and inflammation.

🔹 The GKI may provide a more comprehensive measure of metabolic status than glucose or ketones alone.

🔹 The authors suggest that a GKI of approximately 10 reflects light nutritional ketosis, whereas a GKI of 1–2 or below may be appropriate for therapeutic ketosis in cancer. They further propose that progressively lower GKI values may be appropriate for managing more severe chronic diseases.

The authors propose that mitochondrial dysfunction is a common feature of cancer and many chronic diseases, and that the glucose ketone index (GKI) may provide a practical way to monitor metabolic therapies aimed at restoring metabolic health. Further clinical research is needed to establish disease-specific GKI targets and determine their utility across different conditions.

—

Lee DC, Duraj T, Cooper ID, Maroon JC, Smith K, Abdel-Hadi W, Omene E, Evangeliou AE, Seyfried TN. The glucose ketone index: a proposed quantitative biomarker to support cancer and chronic disease prevention and management. Front Sci. 2026;4:1763395 @drtomasduraj @tnseyfried

📌 Link to study: https://t.co/5DG1UA8h6B

📌 Find more research summaries on our website: https://t.co/iJavUH3WTx

#KetogenicDiet #CancerMetabolism #Mitochondria #GKI #MetabolicHealth

[Keto-Mojo @KetoMojo]

Five-year nutrition studies are rare, but long-term results matter.

A recent study examined whether a digitally delivered, carbohydrate-reduced nutrition program designed to promote nutritional ketosis could help adults with prediabetes maintain long-term metabolic health.

This 5-year extension study followed 96 adults with prediabetes enrolled in a continuous remote care program combining individualized carbohydrate-reduced nutrition therapy with digital health coaching and medical support.

🔹 22% achieved normoglycemia after 5 years, while only 13% progressed to type 2 diabetes.

🔹 Participants maintained an average 5.8 kg (5.3%) weight loss, with 47% achieving at least 5% weight loss.

🔹 Improvements in fasting insulin and insulin resistance (HOMA-IR) were sustained over 5 years.

🔹 The intervention promoted sustained adherence to a carbohydrate-reduced nutrition program, while liver and kidney function remained stable.

The authors conclude that a digitally delivered, individualized carbohydrate-reduced nutrition intervention may support long-term diabetes prevention and metabolic health in adults with prediabetes.

—

Zoller AR, Athinarayanan SJ, Van Tieghem MR, Adams RN, Roberts CGP, Volek JS, Phinney SD, McKenzie AL.Five-Year outcomes of a digitally delivered carbohydrate-reduced nutrition intervention for prediabetes: durability of diabetes prevention. Front Nutr. 2026;13:1839029

📌 Link to study: https://t.co/NWqAECIeXq

📌 Find more research summaries on our website: https://t.co/iJavUH3WTx

#Prediabetes #Type2Diabetes #Ketosis #MetabolicHealth #NutritionResearch

[Keto-Mojo @KetoMojo]

Day 3 of the Symposium for Metabolic Health was full of heavy-hitting speakers! 🔥

It was inspiring to hear @drtonyhampton emphasize the importance of first understanding the problem we're trying to solve for in each particular patient. Once we know that, we can cater to what the individual needs and provide the best tools for success.

For some, like someone with epilepsy or a mental health condition, it may be a ketone meter.

Haven’t checked your ketones yet? 👀

Stop by the Keto-Mojo booth early tomorrow to test, talk metabolic health, and see what your numbers are.

@lowcarbusa @TheSMHP

#MetabolicHealth #RootCauseMedicine #SMHSD2026 #KetoneTesting

[Keto-Mojo @KetoMojo]

Day 2 of Symposium for Metabolic Health was one for the books!

If you missed today's poster session, be sure to stop by tomorrow.

See you for day 3 🩵 @lowcarbusa @TheSMHP

#MetabolicHealth #RootCauseMedicine #MojoMeetup #SMHSD2026